A retrospective non interventional study on first line treatment for patients with BRAF V600E mutant metastatic colorectal cancer (mCRC) (CAPSTAN CRC)

A retrospective non interventional study on first line treatment for patients with BRAF V600E mutant metastatic colorectal cancer (mCRC) (CAPSTAN CRC)

Hide study title
Send by email